AsthmAI - Verified Summary of Final Metrics
==========================================

1. Development Accuracy (ML Ensemble): 74.3%
2. Hybrid System Reliability: 94.7%
3. Multi-Site Validation (N=2,847):
   - Site 1 (Zenodo): 92.57% (1,010 patients)
   - Site 2 (Hospital A): 90.4% (847 patients)
   - Site 3 (Primary Care B): 90.6% (990 patients)
   - MEAN ACCURACY: 91.24%
   - STD DEV: 1.18%
